Epidemiology: yesterday, today, tomorrow (brief overview of history and current issues)
https://doi.org/10.18705/1607-419X-2015-21-3-224-230
Abstract
Epidemiology studies prevalence and determinants of diseases in order to control and prevent health problems. History, aims and tasks of epidemiology are still unclear for researchers and clinicians, although modern evidencebased medicine is based on results of epidemiological observational and interventional studies. Paper gives an overview of epidemiology development and paradigm changes since first attempts by John Graunt until modern conception of prevention paradox suggested by Geoffrey Rose. There is a phenomenon of “epidemiological transition” which is associated with the predominance of non-communicable diseases, in particular, of cardioand cerebrovascular diseases, chronic obstructive pulmonary disease, metabolic disorders, oncological diseases, traumas and stress-related problems, as the main reasons of morbidity and mortality. Currently, there is further progress in epidemiology — population genetics, environmental epidemiology and aging, pharmacoepidemiology and translational epidemiology are becoming more and more popular. Among modern problems of epidemiology, the storing and analysis of Big Data, as well as the necessity of the improvement in data storage and privacy are among the main issues under discussion.
About the Author
O. P. Rotar
Almazov Federal North-West Medical Research Centre, 2 Akkuratov street, St Petersburg, 197341 Russia. Tel: +7(812)702–37–56.
Russian Federation
Russian Federation
MD, PhD, Head, Research Laboratory of Hypertension
Epidemiology, Almazov Federal North-West Medical Research Centre
References
1. Ness RB, Rothenberg R. Critique of epidemiology: Changing the terms of the debate. Ann pidemiol. 2007;17 (12):1011–1012.
2. Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer MJ. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med. 2000;133(12):933–941.
3. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. Writing Group for the Women’s Health Initiative Investigators. J Am Med Assoc. 2002;288(3):321–333.
4. Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. J Am Med Assoc. 2007;297(13):1465–1477.
5. Graunt J. Natural and Political Observations Mentioned in a Following Index and Made Upon the Bills of Mortality. New York: Arno Press; 1975.
6. Davey-Smith G. Behind the Broad Street pump: aetiology, epidemiology and prevention of cholera in mid‑19th century Britain. Int J Epidemiol. 2002;31(5):920–932.
7. Omran AR. The epidemiologic transition. A theory of the epidemiology of population change. Milbank Mem Fund Q. 1971;49 (4):509–538.
8. Omran AR. The epidemiologic transition theory revisited thirty years later. World Health Stat Q. 1998;51:99–119.
9. Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes J 3rd. Factors of risk in the development of coronary heart disease — six year follow-up experience. The Framingham Study. Ann Intern Med. 1961;55:33–50.
10. Washington DC: Government Printing Office; 1964. Health: report of the Advisory Committee to the Surgeon General of the Public Health Service. DHEW publication no. (PHS) 1103.
11. Rose G. Sick individuals and sick populations. Int J Epidemiol. 1985;14(1):32–38.
12. Lilienfeld DE. Definitions of epidemiology. Am J Epidemiol. 1978;107(2):87–90.
13. Embrett MG, Randall GE. Social determinants of health and health equity policy research: exploring the use, misuse, and nonuse of policy analysis theory. Soc Sci Med. 2014;108:147–55.
14. Commentary: Epidemiology and futurology — why did Rothman get it wrong? Cesar G Victora Int. J. Epidemiol. 2007;36 (4):712–713.
15. Ness R, Andrews E, Gaudino J Jr, Newman A, Soskolne C, Sturmer T et al. The future of epidemiology Academic Medicine. 2009;84(11):1631–1637.
16. Hiatt RA, Sulsky S, Aldrich MC, Kreiger N, Rothenberg R. Promoting innovation and creativity in epidemiology for the 21st century. Ann Epidemiol. 2013;23(7):452–454.
17. Khoury MJ, Gwinn M, Yoon PW, Dowling N, Moore CA, Bradley L. The continuum of translation research in genomic medicine: How can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med. 2007;9(10):665–674.
18. Ness RB, Andrews EB, Gaudino JA Jr, Newman AB, Soskolne CL, Stürmer T, Wartenberg DE, Weiss SH. The future of epidemiology. Acad Med. 2009;84(11):1631–1637.
19. Soskolne CL, Butler CD, Ijsselmuiden C, London L, von Schirnding Y. Toward a global agenda for research in environmental epidemiology. Epidemiology. 2007;18(1):162–166.
20. Manton KG, Gu X. Changes in the prevalence of chronic disability in the United States black and nonblack population above age 65 from 1982 to 1999. Proc Natl Acad Sci U S A. 2001;98 (11):6354–6359.
21. Munoz N, Bosch FX, de Sanjose´ S, Herrero R, Castellsagué X, Shah KV et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518–527.
22. Frumkin H, Hess J, Luber G, Malilay J, McGeehin M. Climate change: The public health response. Am J Public Health. 2008;98 (3):435–445. doi: 10.2105/AJPH.2007.119362
23. Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel BS et al. Metagenomic analysis of the human distal gut microbiome. Science. 2006;312(5778):1355–1359.
24. Khoury MJ, Lam T, Ioannidis J, Hartge P, Spitz M, Buring J et al. Transforming epidemiology for 21st century medicine and public health. Cancer Epidemiol Biomarkers Prev. 2013;22 (4):508–516.
25. Hall KL, Feng AX., Moser RP, Stokols D, Taylor BK. Moving the science of team science forward: collaboration and creativity. Am J Prev Med. 2008;35(2 Suppl): S243‑S249.
26. Collins R. What makes UK Biobank special? Lancet. 2012;379(9822):1173–1174.
27. Khoury MJ, Gwinn M, Ioannidis JP. The emergence of translational epidemiology: from scientific discovery to population health impact. Am J Epidemiol. 2010;172(5):517–524.
28. Lam TK, Spitz M, Schully SD, Khoury MJ. “Drivers” of Translational Cancer Epidemiology in the 21st Century: Needs and Opportunities. Cancer Epidemiol Biomarkers Prev. 2013;22 (2):181–188.
29. [Электронный источник]. — URL: https://www.healtheheartstudy.org/
30. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJL. Selected major risk factors and global and regional burden of disease. Lancet. 2002;360(9343):1347–1360.
31. Curtis V, Cairncross S. Effect of washing hands with soap on diarrhoea risk in the community: a systematic review. Lancet Infect Dis. 2003;3(5):275–281.
32. Judah G, Aunger R, Schmidt WP, Michie S, Granger S, Curtis V. Experimental pretesting of hand-washing interventions in a natural setting. Am J Public Health. 2009;99, Suppl 2: S405‑S411.
Review
For citations:
Rotar O.P. Epidemiology: yesterday, today, tomorrow (brief overview of history and current issues). "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2015;21(3):224-230. (In Russ.) https://doi.org/10.18705/1607-419X-2015-21-3-224-230
Views:
1503
Email this article 